UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients

Clinical infectious diseases, 2014-06, Vol.58 (11), p.1549-1553

2014

Volltextzugriff (PDF)

Directly acting antivirals against hepatitis C virus

Journal of antimicrobial chemotherapy, 2011-08, Vol.66 (8), p.1673-1686

2011

Volltextzugriff (PDF)

Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection

Virology (New York, N.Y.), 2014-02, Vol.450, p.336-349

2014

Volltextzugriff (PDF)

Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy

Journal of viral hepatitis, 2008-06, Vol.15 (6), p.427-433

2008

Volltextzugriff (PDF)

Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance

Journal of viral hepatitis, 2011-01, Vol.18 (1), p.11-16

2011

Volltextzugriff (PDF)

Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations

Journal of viral hepatitis, 2009-12, Vol.16 (12), p.895-896

2009

Volltextzugriff (PDF)

Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy

Journal of viral hepatitis, 2014-07, Vol.21 (7), p.475-479

2014

Volltextzugriff (PDF)

Warning on hepatotoxicity of darunavir

AIDS reviews, 2008-01, Vol.10 (1), p.63

Vispo, Eugenia

2008

Volltextzugriff (PDF)

P1068 EFFICACY OF PROLONGED TENOFOVIR THERAPY ON HEPATITIS DELTA IN HIV-INFECTED PATIENTS

Journal of hepatology, 2014-04, Vol.60 (1), p.S433-S433

2014

Volltextzugriff (PDF)

P750 SPONTANEOUS HCV CLEARANCE IN HIV PATIENTS WITH CHRONIC HEPATITIS C BEARING FAVORABLE IL28B ALLELES ON ANTIRETROVIRAL THERAPY

Journal of hepatology, 2014-04, Vol.60 (1), p.S321-S321

2014

Volltextzugriff (PDF)

P755 HEPATITIS C COINFECTION INDEPENDENTLY INCREASES CARDIOVASCULAR RISK IN HIV-INFECTED PATIENTS

Journal of hepatology, 2014-04, Vol.60 (1), p.S322-S322

2014

Volltextzugriff (PDF)

496 CHANGES IN CIRCULATING HCV-RNA CONCENTRATIONS IN PATIENTS WITH CHRONIC HEPATITIS C IN THE ABSENCE OF ANTIVIRAL THERAPY

Journal of hepatology, 2013-04, Vol.58, p.S203-S204

2013

Volltextzugriff (PDF)

985 INCREASING RATES OF ACUTE HEPATITIS C ALONG WITH HIGH RATES OF SYPHILIS IN HIV-POSITIVE MEN WHO HAVE SEX WITH MEN IN MADRID

Journal of hepatology, 2013-04, Vol.58, p.S405-S406

2013

Volltextzugriff (PDF)

1376 LIVER TOXICITY OF THE MOST RECENTLY APPROVED ANTIRETROVIRAL DRUGS IN HIV-INFECTED PATIENTS - OVERALL LOW RATE BUT INCREASED IN THE PRESENCE OF CHRONIC HEPATITIS C

Journal of hepatology, 2012-04, Vol.56, p.S540-S541

2012

Volltextzugriff (PDF)

770 HCV RELAPSES UPON COMPLETION OF PEG-INTERFERON PLUS RIBAVIRIN IN HIV-INFECTED PATIENTS: RATE, TIMING AND PREDICTORS

Journal of hepatology, 2008, Vol.48, p.S287-S287

2008

Volltextzugriff (PDF)

P558 IMPACT OF SCREENING ON SURVIVAL OF HEPATOCELLULAR CARCINOMA (HCC) IN HIV/HBV-COINFECTED PATIENTS

Journal of hepatology, 2014-04, Vol.60 (1), p.S255-S255

2014

Volltextzugriff (PDF)

Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients

Journal of viral hepatitis, 2011-05, Vol.18 (5), p.325-330

2011

Volltextzugriff (PDF)

P559 CONTINENTAL DIFFERENCES AMONG HIV-INFECTED PATIENTS WITH HEPATOCELLULAR CARCINOMA: EUROPE VS. NORTH AMERICA

Journal of hepatology, 2014-04, Vol.60 (1), p.S255-S256

2014

Volltextzugriff (PDF)

354 LIVER FIBROSIS PROGRESSION IN HIV+ PATIENTS UNDER DISTINCT ANTIRETROVIRAL DRUGS

Journal of hepatology, 2011-03, Vol.54, p.S142-S142

2011

Volltextzugriff (PDF)

838 DISTINCT HEPATITIS C VIRUS KINETICS IN HIV+ PATIENTS TREATED WITH RIBAVIRIN PLUS EITHER PEGYLATED INTERFERON ALFA-2A OR ALFA-2B

Journal of hepatology, 2008, Vol.48, p.S314-S314

2008

Volltextzugriff (PDF)

1321 DIFFERENT INFLUENCE OF HCV-SPECIFIC T-CELL RESPONSES AND RS12979860 IL28B GENOTYPES ON KINETICS OF HCV CLEARANCE IN PATIENTS TREATED WITH PEGINTERFERON-RIBAVIRIN

Journal of hepatology, 2011-03, Vol.54, p.S520-S521

2011

Volltextzugriff (PDF)

1159 NON-CIRRHOTIC PORTAL HYPERTENSION IN HIV-INFECTED PATIENTS: UNIQUE CLINICAL AND PATHOLOGICAL FEATURES

Journal of hepatology, 2010, Vol.52, p.S447-S448

2010

Volltextzugriff (PDF)

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

AIDS (London), 2009-03, Vol.23 (6), p.689-696

2009

Volltextzugriff (PDF)

Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients

AIDS (London), 2010-05, Vol.24 (8), p.F23-F29

2010

Volltextzugriff (PDF)

Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome

Journal of viral hepatitis, 2008-03, Vol.15 (3), p.165-172

2008

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(120)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Humans
(66)
Life Sciences & Biomedicine
(66)
Infectious Diseases
(56)
Human Immunodeficiency Virus
(47)
Male
(46)
Female
(43)
Adult
(41)
Biological And Medical Sciences
(36)
Hiv Infections - Drug Therapy
(36)
Immunology
(36)
Medical Sciences
(36)
Human Viral Diseases
(35)
Viral Diseases
(35)
Virology
(34)
Hiv
(33)
Hiv Infections - Complications
(30)
Middle Aged
(28)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(27)
Hepatitis C Virus
(25)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients

Directly acting antivirals against hepatitis C virus

Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection

Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy

Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance

Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations

Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy

Warning on hepatotoxicity of darunavir

P1068 EFFICACY OF PROLONGED TENOFOVIR THERAPY ON HEPATITIS DELTA IN HIV-INFECTED PATIENTS

P750 SPONTANEOUS HCV CLEARANCE IN HIV PATIENTS WITH CHRONIC HEPATITIS C BEARING FAVORABLE IL28B ALLELES ON ANTIRETROVIRAL THERAPY

P755 HEPATITIS C COINFECTION INDEPENDENTLY INCREASES CARDIOVASCULAR RISK IN HIV-INFECTED PATIENTS

496 CHANGES IN CIRCULATING HCV-RNA CONCENTRATIONS IN PATIENTS WITH CHRONIC HEPATITIS C IN THE ABSENCE OF ANTIVIRAL THERAPY

985 INCREASING RATES OF ACUTE HEPATITIS C ALONG WITH HIGH RATES OF SYPHILIS IN HIV-POSITIVE MEN WHO HAVE SEX WITH MEN IN MADRID

1376 LIVER TOXICITY OF THE MOST RECENTLY APPROVED ANTIRETROVIRAL DRUGS IN HIV-INFECTED PATIENTS - OVERALL LOW RATE BUT INCREASED IN THE PRESENCE OF CHRONIC HEPATITIS C

770 HCV RELAPSES UPON COMPLETION OF PEG-INTERFERON PLUS RIBAVIRIN IN HIV-INFECTED PATIENTS: RATE, TIMING AND PREDICTORS

P558 IMPACT OF SCREENING ON SURVIVAL OF HEPATOCELLULAR CARCINOMA (HCC) IN HIV/HBV-COINFECTED PATIENTS

Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients

P559 CONTINENTAL DIFFERENCES AMONG HIV-INFECTED PATIENTS WITH HEPATOCELLULAR CARCINOMA: EUROPE VS. NORTH AMERICA

354 LIVER FIBROSIS PROGRESSION IN HIV+ PATIENTS UNDER DISTINCT ANTIRETROVIRAL DRUGS

838 DISTINCT HEPATITIS C VIRUS KINETICS IN HIV+ PATIENTS TREATED WITH RIBAVIRIN PLUS EITHER PEGYLATED INTERFERON ALFA-2A OR ALFA-2B

1321 DIFFERENT INFLUENCE OF HCV-SPECIFIC T-CELL RESPONSES AND RS12979860 IL28B GENOTYPES ON KINETICS OF HCV CLEARANCE IN PATIENTS TREATED WITH PEGINTERFERON-RIBAVIRIN

1159 NON-CIRRHOTIC PORTAL HYPERTENSION IN HIV-INFECTED PATIENTS: UNIQUE CLINICAL AND PATHOLOGICAL FEATURES

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients

Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome

Suchergebnisse filtern